Evidence map›Paper›PMID 36378340›Full record

ArticleJournal of cancer research and clinical oncology2023

A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches.

Reyhaneh Aghayousefi, Seyed Mahdi Hosseiniyan Khatibi, Sepideh Zununi Vahed, Milad Bastami, Saeed Pirmoradi, Mohammad Teshnehlab

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Reyhaneh Aghayousefi *Department of Electrical Engineering, K.N. Toosi University of Technology, Tehran, Iran.
Seyed Mahdi Hosseiniyan Khatibi *Clinical Research Development Unit of Tabriz Valiasr Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
Sepideh Zununi Vahed *Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Milad BastamiNon-Communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Saeed PirmoradiClinical Research Development Unit of Tabriz Valiasr Hospital, Tabriz University of Medical Sciences, Tabriz, Iran. said.pirmoradi@gmail.com.
Mohammad TeshnehlabDepartment of Electrical Engineering, K.N. Toosi University of Technology, Tehran, Iran. teshnehlab@eetd.kntu.ac.ir.
Tabriz University of Medical Sciences · IRK.N.Toosi University of Technology · IRFasa University of Medical Sciences · IR

Funding

Kidney Research Center, Tabriz University of Medical Science, Tabriz, Iran 70349
6 · The paper itself

Abstract

backgroundOvarian Cancer (OC) is the deadliest gynecology malignancy, whose high recurrence rate in OC patients is a challenging object. Therefore, having deep insights into the genetic and molecular mechanisms of OC recurrence can improve the target therapeutic procedures. This study aimed to discover crucial miRNAs for the detection of tumor recurrence in OC by artificial intelligence approaches.

methodThrough the ANOVA feature selection method, we selected 100 candidate miRNAs among 588 miRNAs. For their classification, a deep-learning model was employed to validate the significance of the candidate miRNAs. The accuracy, F1-score (high-risk), and AUC-ROC of classification test data based on the 100 miRNAs were 73%, 0.81, and 0.65, respectively. Association rule mining was used to discover hidden relations among the selected miRNAs.

resultFive miRNAs, including miR-1914, miR-203, miR-135a-2, miR-149, and miR-9-1, were identified as the most frequent items among high-risk association rules. The identified miRNAs may target genes/proteins involved in epithelial-mesenchymal transition (EMT), resistance to therapy, and cancer stem cells; being responsible for the heterogeneity and plasticity of the tumor. Our conclusion presents mir-1914 as the significant candidate miRNA and the most frequent item. Current knowledge indicates that the dysregulated miR-1914 may function as a tumor suppressor or oncogene in the development of cancer.

conclusionThese candidate miRNAs can be considered a powerful tool in the diagnosis of OC recurrence. We hypothesize that mir-1914 might open a new line of research in the realm of managing the recurrence of OC and could be a significant factor in triggering OC recurrence.

Indexed as

MicroRNAsOvarian NeoplasmsArtificial IntelligenceFemaleGene Expression Regulation, NeoplasticGenes, Tumor SuppressorHumansNeoplasm Recurrence, LocalMicroRNAsMIRN149 microRNA, humanMIRN203 microRNA, humanAssociation rule miningCancer recurrenceDeep learningMachine learningmiRNAOvarian cancer

Identifiers

PMID36378340
PMCPMC11798003
OpenAlexW4309096348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.